VS
Vishnu Sunil Jaikumar
Rajiv Gandhi Centre for Biotechnology, University of South Australia, Tamil Nadu Veterinary and Animal Sciences University, Kerala Veterinary and Animal Sciences University
Employment
-
Rajiv Gandhi Centre for Biotechnology Veterinary Medical Officer2019 - 2022
-
Rajiv Gandhi Centre for Biotechnology Research Associate III2016 - 2019
Education
-
University of South Australia PhD2023 - Present
-
Tamil Nadu Veterinary and Animal Sciences University Certificate in Laboratory Animal Science (FELASA A, B, C, D)2017 - 2017
-
Kerala Veterinary and Animal Sciences University Master of Veterinary Science2012 - 2015
-
Rajiv Gandhi Institute of Veterinary Education and Research Bachelor of Veterinary Science and Animal Husbandry2007 - 2012
Projects & Funding
Projects & funding information is unavailable.
Publications (28)
- EPHA2-Ephrin-B1 cis-interaction drives an oncogenic reverse signaling, leading to the recurrence of oral cancer Save
- Orphan drug uttroside B impedes MASH progression and HCC development in experimental models Save
- Uttroside B, a US FDA-designated ‘Orphan Drug’, mitigates the development of hepatocellular carcinoma and its pulmonary metastasis via EGFR/ERK-mediated inhibition of SREBP-1 and STAT-3 Save
- TIF1γ drives oral cancer recurrence by the transcriptional regulation of self-renewal genes, such as HES1 Save
- Decoding BRCA1 promoter hypermethylation: a new frontier in understanding sporadic breast cancer Save
- Probiotic Lacticaseibacillus paracasei from human gut microbiome against colistin-resistant Klebsiella pneumoniae: in vitro, in vivo and probiogenomic approaches Save
- Elucidating the Role of MicroRNA-18a in Propelling a Hybrid Epithelial-Mesenchymal Phenotype and Driving Malignant Progression in ER-Negative Breast Cancer Save
- Targeting Ezrin Can Impede Transformation of Cancer Associated Fibroblast (Caf) to Metastasis Associated Fibroblasts (Maf) in Brca1 Defective Triple Negative Breast Cancers Save
- Urolithin A, induces apoptosis and autophagy crosstalk in Oral Squamous Cell Carcinoma via mTOR /AKT/ERK1/2 pathway Save
- Uttroside B, a US-FDA-Designated Orphan Drug Against Hepatocellular Carcinoma (HCC), Impedes Non-alcoholic Steatohepatitis (NASH) and NASH -Induced HCC Save